We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AQST market cap is 331.89M. The company's latest EPS is USD -0.0863 and P/E is -42.18.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13M | 13.21M | 12.05M | 20.1M | 13.54M |
| Operating Income | -2.38M | -3.91M | -8.96M | 55k | -8.29M |
| Net Income | -2.04M | -8.11M | -12.83M | -2.75M | -11.51M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 52.61M | 45.85M | 50.83M | 47.68M | 50.58M |
| Operating Income | -52.67M | -42.89M | -34.68M | -42.07M | -15.1M |
| Net Income | -66.25M | -55.78M | -70.54M | -54.41M | -7.87M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.45M | 57.42M | 129.52M | 117.61M | 109.96M |
| Total Liabilities | 162.38M | 163.91M | 165.82M | 153.08M | 155.38M |
| Total Equity | -102.93M | -106.49M | -36.3M | -35.48M | -45.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 78.48M | 62.88M | 61.99M | 57.07M | 57.42M |
| Total Liabilities | 84.6M | 111.38M | 144.13M | 175.62M | 163.91M |
| Total Equity | -6.12M | -48.5M | -82.13M | -118.55M | -106.49M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.44M | -6.38M | -10.38M | -17.39M | -29.27M |
| Investing | -979k | -995k | -29k | -64k | -144k |
| Financing | 61k | 3.97M | 81.74M | 83.45M | 83.44M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -60.21M | -45.46M | -32.98M | -9.79M | -6.38M |
| Investing | -663k | -517k | -913k | -2.52M | -995k |
| Financing | 49.6M | 28.46M | 30.11M | 11.56M | 3.97M |
| Market Cap | 331.89M |
| Price to Earnings Ratio | -42.18 |
| Price to Sales Ratio | 6.56 |
| Price to Cash Ratio | 13.9 |
| Price to Book Ratio | -3.12 |
| Dividend Yield | - |
| Shares Outstanding | 91.18M |
| Average Volume (1 week) | 1.88M |
| Average Volume (1 Month) | 1.65M |
| 52 Week Change | 86.67% |
| 52 Week High | 6.23 |
| 52 Week Low | 1.84 |
| Spread (Intraday) | 0.02 (0.54%) |
| Company Name | Aquestive Therapeutics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.aquestive.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
